Cargando…
The Effect of Chinese Medicine on Lipid and Glucose Metabolism in Acute Myocardial Infarction Through PPARγ Pathway
Aim: Danqi Pill (DQP), a Chinese medicine frequently prescribed in China, has been approved to improve cardiac function by regulating cardiac energy metabolism in heart failure (HF) after acute myocardial infarction (AMI) patients. The aim of this study was to explore whether the mechanism of DQP is...
Autores principales: | Zhang, Qian, Shao, Mingyan, Zhang, Xuefeng, Wang, Qiyan, Guo, Dongqing, Yang, Xiaomin, Li, Chun, Wang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207917/ https://www.ncbi.nlm.nih.gov/pubmed/30405421 http://dx.doi.org/10.3389/fphar.2018.01209 |
Ejemplares similares
-
Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway
por: Zhang, Qian, et al.
Publicado: (2020) -
Pro-angiogenic Role of Danqi Pill Through Activating Fatty Acids Oxidation Pathway Against Coronary Artery Disease
por: Jiao, Shihong, et al.
Publicado: (2018) -
Gegen Qinlian Decoction Coordinately Regulates PPARγ and PPARα to Improve Glucose and Lipid Homeostasis in Diabetic Rats and Insulin Resistance 3T3-L1 Adipocytes
por: Tu, Jun, et al.
Publicado: (2020) -
Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction
por: Wang, Yu, et al.
Publicado: (2022) -
Multipronged Therapeutic Effects of Chinese Herbal Medicine Qishenyiqi in the Treatment of Acute Myocardial Infarction
por: Wang, Yong, et al.
Publicado: (2017)